Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Dr. Reddy's Laboratories Ltd.
NSE: DRREDDY
|
BSE: 500124
|
ISIN: INE089A01031
|
Industry: Pharmaceuticals
US FDA Observation
|
Turnaround Potential
1310.0000
9.20
(
0.71
%)
NSE
Sep 16, 2025
13:40 PM
28.43% Gain from 52W Low
Volume:
448.2K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Dr. Reddy's Laboratories Ltd.
29 Jul 2022
US FDA Observation
1310.00
0.71%
DR REDDY'S LABS
Buy:
Dr. Reddy's Laboratories Ltd.
by
Prabhudas Lilladhar
Target: 4750
Target
Prabhudas Lilladhar
Deven Choksey released a Sell report for Dr. Reddy's Laboratories Ltd. with a price target of 1120.0 on 11 Sep, 2025.
More from Dr. Reddy's Laboratories Ltd.
Recommended
Market trades higher, Insolation Energy bags a Rs 113 crore order from JDVVNL for solar power plants
Trendlyne Marketwatch |
16 Sep 2025, 01:25PM
IPO market buzz: Five new issues, eleven listings this week
|
15 Sep 2025, 04:32PM
Dr Reddy’s Labs struggles in its biggest market
|
18 Aug 2021